Litigation Update: We are currently only accepting cases where the first diagnosis occurred after July 1, 2017, and for patients who had extensive and prolonged exposure to Roundup®.
In 2015, the World Health Organization and the International Agency for Research on Cancer released a study that concluded that the handling and use of glyphosate, the active ingredient in the popular herbicide Roundup®, “probably carcinogenic in humans” and probably causes non-Hodgkin lymphoma (NHL) or one of its sub-types. Other studies have even found that it doubles your risk of developing the cancer. Monstanto, the multi-national company that owns and manufactures Roundup, has maintained that the chemical is safe, even go so far as to ghostwrite research papers that show as much. The Environmental Protection Agency is currently reviewing its classification of “not likely” to cause cancer. This review is normal and occurs about every 15 years. Earlier this year, the California Environmental Protection Agency added glyphosate to its Proposition 65 list of carcinogenic chemicals. For more information about non-Hodgkin Lymphoma in general, click here.
Monsanto developed glyphosate in the early 1970s, bringing it to market under the trade name Roundup in 1974. Monsanto’s patent for the product expired in 2000, allowing other companies to sell generic versions of the chemical. Glyphosate is the most successful weed killer in history. In 2015 alone, Monstanto generated nearly $5 Billion in sales of herbicide products, mostly Roundup.
For a case to be viable, the person must have had direct exposure to the chemical, either by handling it or applying it, or by being nearby when it was being applied. Long-term exposure is also a higher indicator that the chemical caused the cancer. Exposure can occur by either inhalation or by direct skin contact.
Types of Cancer
A lymphoma is a group of blood-cell tumors that develop from lymphocytes, which are a type of white blood cell. B-cells and T-cells are two types of lymphocytes that commonly develop lymphomas. Non-Hodgkin lymphoma is the most common type of lymphoma, with about 90% of all lymphomas being NHL. The other types, which are not related to glyphosate, include Hodgkin’s lymphoma, multiple mlyeloma, and immunoproliferative diseases. Diagnosis is usually accomplished by a biopsy of the lymph nodes, or by blood, urine, or bone-marrow testing. Imaging is then used to find where the cancer has spread. The most common tissues lymphomas spread to are brain, liver, and lung.
B-Cell and T-Cell lymphomas are the most common sub-types of non-Hodgkin lymphoma, and these are linked to glyphosate. Many other sub-types are also linked. We are accepting all stages of non-Hodgkin Lymphoma diagnosis, from stage one through stage four.
B-cell non-Hodgkin lymphomas include Burkitt lymphoma, chronic lymphocytic leukemia(CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma, follicular lymphoma, immunoblastic large cell lymphoma, precursor B-lymphoblastic lymphoma, and mantle cell lymphoma.
T-cell non-Hodgkin lymphomas include mycosis fungoides, anaplastic large cell lymphoma, and precursor T-lymphoblastic lymphoma.
Currently there are several law suits pending around the country, including a federal law suit in Northern California, and state court cases in Nebraska, Missouri, and Delaware. It is critical that you contact a qualified personal injury attorney immediately to assess your case. Waiting until after important legal deadlines have passed could result in your case being worth much less, or even nothing. We are currently only accepting cases where first diagnosis occurred in 2017.
Many of the current plaintiffs are farmers, agriculture workers, tree nursery workers, family members of those previously listed, and even home gardeners. The lawsuits allege, in part, that Monsanto does not properly warn that glyphosate is a carcinogen, and that the exposure to glyphosate, more likely than not, caused their non-Hodkin Lymphoma cancer.
What is My Case Worth?
It is very difficult to give an estimate on case value at this stage, mainly because none of the present cases have settled or gone to trial. Typical mass tort cases like these will take one or two cases to trial early on—called bellwether trials—in order to get an idea of what juries will award. Once the bellwether trials have concluded, the lawyers on both sides try to work together to come to an agreed settlement for the remaining plaintiffs.
As with any personal injury case, the value of the case depends on the degree of damages. A plaintiff who had stage one NHL, completed treatment in a short amount of time, and is in remission will not have a case worth as much as someone who has a much longer, more-difficult battle with the cancer.
Protect Your Rights—Take Action Now
We are encouraging anyone in the farming industry who has been exposed to Roundup or glyphosate and has also been diagnosed with non-Hodgkin lymphoma to call today to speak with an attorney. There is no risk; initial consultations and phone calls are always free.
Roundup® and Monsanto are trademarks of Monsanto Company